Antimicrobial strategy for device implantation
Part of Infections clinical trials.
This trial tests a new antimicrobial approach to prevent infections in people receiving a cardiac implantable electronic device (CIED) or having a generator replacement. If you are scheduled for one of these procedures, this study may help reduce your risk of infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You need a CIED (like a pacemaker or defibrillator) implanted or your current device's generator replaced.
- You are willing to provide written consent to participate.
- You are not allergic to taurolidine or any of its ingredients.
- You do not have a severely weakened immune system (for example, from chemotherapy, AIDS, or organ transplant medications).
- You are not expected to live less than 12 months due to other serious illnesses, and you are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing an approach to improve how clinicians care for people with suspected infections around an implanted heart device (like a pacemaker or defibrillator). It may help ensure the infection is recognized and treated appropriately, especially when device removal (extraction) might be needed.
This study tests a new alert system for people with pacemakers or defibrillators. It sends early warnings to your care team when the device detects a problem, so they can help you faster—without extra visits.
This trial is testing whether a shorter course of antibiotics (instead of the usual longer course) is safe and effective for people who have had an infection on the wires of their pacemaker or defibrillator, after the device has been completely removed.
This trial compares removing a heart device (like a pacemaker) versus using antibiotics and other medical care to treat an infection. It may help doctors decide the best way to handle infections related to these devices.
This study tests a new alert system for people with pacemakers or defibrillators that can send information directly to your care team. The goal is to improve how quickly problems are found and treated.
This trial tests if the antibiotic oritavancin can fight stubborn infections in pacemakers or similar heart devices caused by bacteria resistant to standard treatments. It may help people who cannot take common antibiotics due to allergies.
Hear when a new CIED-related Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.